Arcadia Biosciences Inc (NAS:RKDA)
$ 4.24 0.19 (4.69%) Market Cap: 5.78 Mil Enterprise Value: -2.01 Mil PE Ratio: 0 PB Ratio: 0.49 GF Score: 66/100

Q2 2021 Arcadia Biosciences Inc Earnings Call Transcript

Aug 16, 2021 / 08:30PM GMT
Release Date Price: $91.6 (-2.55%)
Operator

Good afternoon, and welcome to Arcadia Biosciences Second Quarter 2021 Earnings Conference Call. Today's presenters will be Matt Plavan, President and CEO; and Pam Haley, Chief Financial Officer of Arcadia. This call is being webcast, and you can refer to the company's press release at arcadiabio.com.

Before we start, we would like to remind you that Arcadia Biosciences will be making forward-looking statements on this call based on current expectations and currently available information. However, since these statements are based on factors that involve risks and uncertainties, the company's actual performance and results may differ materially from those described or implied today. You can review or -- you can review the company's safe harbor language in their most recently filed 10-Q.

With that, I will now turn the call over to Matt Plavan, President and CEO.

Matthew T. Plavan
Arcadia Biosciences, Inc. - President, CEO & Director

Thank you, Josh, and hello, everyone. Welcome to our second quarter conference call, and thank you for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot